Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin as augmentation for treatment-resistant depression
NCT03435744Phase 3Completed
- Sponsor
- Pakistan Institute of Living and Learning
- Start
- Jan 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of simvastatin in major depressive disorder (MDD), sponsored by Pakistan Institute of Living and Learning. Started Jan 2019; status: completed.
02
Drugs
simvastatin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03435744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03435744.